Apr 7, 2022
The legal principles discussed also apply to individuals with other types of substance use disorders.
Apr 7, 2022
In this webinar, Hazelden Betty Ford’s Stephen Delisi, MD, will examine the growing rates of substance use disorder and the impact of opioids and fentanyl on communities through his role consulting with health systems and medical professionals across the country. To focus on one health system’s…
Jan 21, 2022
AHA letter to Representative Donald Norcross expressing support for bipartisan legislation, the Opioid Treatment Access Act (H.R. 6279).
Oct 18, 2021
Nearly three-fourths of the 2.4 million U.S. adults who reported using buprenorphine in 2019 did not misuse the medication in the past 12 months, according to a National Institutes of Health study released in JAMA Network Open.
Jun 22, 2021
Strategies for opioid stewardship. This Transformation Talks video explores steps providers can take to help address the opioid crisis.
Apr 26, 2021
UChicago Medicine found an opportunity to enhance inpatient treatment for opioid use disorder by leveraging non-specialist clinical expertise and collaborating with local community-based treatment providers. Read more from George Weyer, M.D., about this successful consult service and how it formed.
Apr 21, 2021
Access to behavioral health care unfortunately remains difficult due to the shortage of providers, stigma, lack of a true connected continuum of care, and more. This series of case studies featuring the innovative work of hospitals and health systems and their community partners, details how…
Jan 25, 2021
This webinar is presented by: Sarah E. Wakeman, MD Medical Director, Massachusetts General Hospital Substance Use Disorder Initiative Medical Director, Massachusetts General Hospital Addiction Consult Team Director, Addiction Medicine Fellowship Program Associate Professor of Medicine, Harvard…
Dec 3, 2020
About two years ago, the Buprenorphine Team — or B team — was formed at Dell Seton Medical Center in Austin, Texas, in collaboration with Dell Medical School at the University of Texas at Austin. Our goal is to offer Food and Drug Administration (FDA)-approved medications for patients with opioid…